Excess belly fat is a common side effect for patients treating HIV. Egrifta has been shown to reduce this in HIV-infected patients. To encourage adherence, patients receive a series of educational and informative newsletters to help support them. For full pdfs, click here and here.

Egrifta nwsltr thumbnail issue 1.jpg
Egrifta nwsltr thumbnail issue 2.jpg

This engaging and educational Healthy Living book gives patients suggestions for living a healthy lifestyle. For full pdf, click here.

Egrifta_HIV healthy living cover thumbnail.jpg